Ronald S. Michalak

Optimization of 6,7-Disubstituted-4-(arylamino)quinoline-3-carbonitriles as Orally Active, Irreversible Inhibitors of Human Epidermal Growth Factor Receptor-2 Kinase Activity

Hwei‐Ru Tsou, Elsebe G. Overbeek-Klumpers, William Hallett et al. · Journal of Medicinal Chemistry · 2005 · 299 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Directed dilithiation of hexafluorocumyl alcohol - formation of a reagent for the facile introduction of a stabilizing bidentate ligand in compounds of hypervalent sulfur (10-S-4), phosphorus (10-P-5), silicon (10-Si-5), and iodine (10-I-3)

Edmund F. Perozzi, Ronald S. Michalak, Garret D. Figuly et al. · The Journal of Organic Chemistry · 1981 · 138 citations

Natural Sciences, Chemistry, Inorganic Chemistry +10

Indole Cytosolic Phospholipase A₂α Inhibitors: Discovery and in Vitro and in Vivo Characterization of 4-{3-[5-Chloro-2-(2-{[(3,4-dichlorobenzyl)sulfonyl]amino}ethyl)-1-(diphenylmethyl)-1<i>H</i>-indol-3-yl]propyl}benzoic Acid, Efipladib

John C. McKew, Katherine L. Lee, Marina W. H. Shen et al. · Journal of Medicinal Chemistry · 2008 · 88 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

Nondissociative permutational isomerization of an octahedral derivative of a nonmetallic element, a 12-Te-6 species

Ronald S. Michalak, Scott R. Wilson, J. C. Martin · Journal of the American Chemical Society · 1984 · 66 citations

Natural Sciences, Chemistry, Inorganic Chemistry +8

A Convenient Large Scale Synthesis of Protected D-Ribonolactone From D-Ribose

Bashir Kaskar, G. L. Heise, Ronald S. Michalak et al. · Synthesis · 1990 · 55 citations

Natural Sciences, Chemistry, Medicinal Chemistry +6